Mustang Bio (MBIO) Change in Acquisitions & Divestments (2017 - 2019)
Mustang Bio (MBIO) posted quarterly Change in Acquisitions & Divestments of $5.1 million for Q2 2019, down 57.47% year-over-year from $12.0 million in Q2 2018, and down 59.17% quarter-over-quarter from $12.5 million in Q1 2019.
Mustang Bio (MBIO) Change in Acquisitions & Divestments (2017 - 2019) Analysis & Trends
Mustang Bio (MBIO) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $5.1 million the latest figure, recorded in Q2 2019.
- In Q2 2019, Change in Acquisitions & Divestments fell 57.47% year-over-year to $5.1 million; the TTM figure through Mar 2020 stood at $5.1 million (down 91.42% YoY), while the FY2019 annual figure was $17.6 million, down 71.14% from the prior year.
- Change in Acquisitions & Divestments slipped to $5.1 million in Q2 2019 per MBIO's latest filing, from $12.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $25.0 million in Q3 2018 and bottomed at $5.1 million in Q2 2019.
- Historically, Change in Acquisitions & Divestments has averaged $14.1 million across 3 years, with a median of $12.5 million in 2019.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 10.71% in 2019 and fell as far as 57.47% in 2019.
- Mustang Bio's Change in Acquisitions & Divestments stood at $20.0 million in 2017, then slumped by 50.0% to $10.0 million in 2018, then sank by 48.96% to $5.1 million in 2019.
- Business Quant data shows MBIO's Change in Acquisitions & Divestments at $5.1 million in Q2 2019, $12.5 million in Q1 2019, and $10.0 million in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 5.10 Mn |
| Jun 30, 2019 | 5.10 Mn |
| Mar 31, 2019 | 12.50 Mn |
| Mar 31, 2019 | 12.50 Mn |
| Dec 31, 2018 | 10.00 Mn |
| Dec 31, 2018 | 10.00 Mn |
| Sep 30, 2018 | 25.00 Mn |
| Sep 30, 2018 | 25.00 Mn |
| Jun 30, 2018 | 12.00 Mn |
| Jun 30, 2018 | 12.00 Mn |
| Mar 31, 2018 | 14.00 Mn |
| Mar 31, 2018 | 14.00 Mn |
| Dec 31, 2017 | 20.00 Mn |
| Dec 31, 2017 | 20.00 Mn |